http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View More Recent Stories
-
Guardant Health (GH) Receives FDA Approval for Guardant360 CDx as Companion Diagnostic for for ENHERTU
-
Guardant Health Receives FDA Approval for Guardant360® CDx as Companion Diagnostic for Daiichi Sankyo and AstraZeneca’s ENHERTU® for Treatment of NSCLC Patients With Activating HER2 Mutations
-
Guardant Health and Blueprint Medicines present real-world data identifying EGFR C797X mutation as most common resistance mechanism to osimertinib therapy at IASLC 2022 World Conference on Lung Cancer
-
Guardant Health (GH) Reports New Data from its Portfolio of Blood Tests and GuardantINFORM Platform
-
Guardant Health Announces New Data from its Portfolio of Blood Tests and GuardantINFORM™ Real-World Clinical-Genomic Platform at IASLC 2022 World Conference on Lung Cancer
-
Guardant Health (GH) Receives Medicare Coverage for Guardant Reveal Test
-
Guardant Health Receives Medicare Coverage for Guardant Reveal™ Test
-
Guardant Health to Report Second Quarter 2022 Financial Results on August 4, 2022
-
Guardant Health (GH) Announces Steve E. Krognes Joins Board of Directors
-
Steve E. Krognes Joins Guardant Health Board of Directors
-
Guardant Health (GH) and Adicon Partner to Offer Genomic Profiling Tests in China
-
Guardant Health and Adicon announce strategic partnership to offer comprehensive genomic profiling tests to accelerate development of new cancer therapies in China
-
Guardant Health Completes Purchase of Guardant Health AMEA Joint Venture
-
Guardant Health (GH) Adds Vijaya Gadde to Board
-
Guardant Health Appoints Vijaya Gadde to its Board of Directors
